A rapid method for the preparation of 125I-labelled human growth hormone for receptor studies, using reverse-phase high performance liquid chromatography.
Human growth hormone was labelled with 125 Iodine by the stoichiometric modification of the chloramine-T method to a specific activity of 50-80 microCi/microgram, and the iodinated mixture was purified by reverse-phase high performance liquid chromatography using a C18 column (SynChropak RP-P) and a linear gradient. Compared with the usual Sephadex G-100 chromatography, HPLC gave a much better separation, with a higher yield and a considerably reduced analysis time (30 min vs 5 h). The [125I]-labelled preparation had normal binding to IM-9 lymphocyte receptors. The maximum bindability of the HPLC-purified preparation approximated 90%, which is the best value so far reported for human growth hormone. It is concluded that HPLC is a fast, convenient and reproducible method for obtaining an improved [125I]-labelled human growth hormone for receptor studies.
D002851:Chromatography, High Pressure Liquid; D013006:Growth Hormone / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D007457:Iodine Radioisotopes; D007467:Iodoproteins / Q000276:immunology / Q000302:isolation & purification; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011986:Receptors, Somatotropin
D007457:Iodine Radioisotopes; D007467:Iodoproteins; D011956:Receptors, Cell Surface; D011986:Receptors, Somatotropin; D013006:Growth Hormone